Knowledge Article

Why Karisma Rh Collagen Differs From Typical Collagen Boosters

Key Takeaway

Karisma Rh Collagen is a collagen precursor designed to support type I collagen production, with a mechanism distinct from standard fillers and some biostimulators.

Why Karisma Rh Collagen Differs From Typical Collagen BoostersAnchor

The aesthetic medicine market currently offers many collagen-stimulating (biostimulator) products, most of which work through "controlled inflammation" — injecting substances such as Poly-L-lactic acid or Calcium hydroxylapatite to trigger a micro-wound healing response that, in turn, stimulates collagen production.

Karisma Rh Collagen® takes a different approach, built on Recombinant Human Collagen (Rh Collagen) technology — an α1 polypeptide chain of type I collagen produced via transgenic silkworm technology. This involves genetically modifying silkworms to produce human collagen protein in place of part of the sericin protein normally found in silk, yielding a collagen precursor structurally close to natural human collagen.

Core Components of the ProductAnchor

Karisma Rh Collagen FACE contains three main components:

  1. Rh Collagen (α1 polypeptide chain of type I collagen) — serves as a precursor that stimulates dermal fibroblasts to produce more procollagen type I C-peptide, a key step that helps procollagen molecules coil into the triple-helix structure central to natural collagen formation.
  2. High molecular weight hyaluronic acid — provides hydration and creates an environment favourable for fibroblast growth.
  3. Carboxymethylcellulose (CMC) — a semi-synthetic substance that inhibits the hyaluronidase enzyme responsible for breaking down hyaluronic acid, helping existing hyaluronic acid in the tissue last longer.

What the Scientific Evidence ShowsAnchor

In vitro studies testing the Karisma Rh Collagen formulation on both normal and aged human dermal fibroblasts found that it stimulated fibroblast proliferation and migration in a dose-dependent manner. A separate clinical study involving 100 subjects, grouped by skin condition, smoking history, and facial scarring, evaluated the formulation's effectiveness in skin regeneration. These findings, published in peer-reviewed journals, are promising preliminary evidence — but I want to be clear that the body of research is still limited compared with fillers or biostimulators that have been used clinically for decades, so longer-term data is still needed.

Manufacturer-Stated IndicationsAnchor

According to the manufacturer, Karisma Rh Collagen FACE is classified as an injectable, resorbable medical device, indicated for skin laxity, loss of firmness, tissue atrophy, marionette lines, fine wrinkles, and scarring.

What I Want Patients to Understand CorrectlyAnchor

I've noticed that marketing descriptions for products in this category sometimes use language that overstates certainty — phrases like "100% safe" or "the body uses it 100%." Medically speaking, no injectable procedure is entirely free of risk. While Rh Collagen has a structure close to human collagen and available studies describe it as non-immunogenic, it still involves injecting a substance into the skin, which carries the general risks of any injectable procedure — bruising, swelling, redness, or localised reactions — the same as any other injection-based treatment.

Also worth clarifying: the manufacturer's description of a mechanism that doesn't rely on "an inflammatory process" refers to not depending primarily on micro-wound stimulation the way some biostimulators do — it doesn't mean the body has zero biological response after injection. Injecting any substance into the skin naturally triggers some level of biological response.

Who Should Consider This, and How to PrepareAnchor

Patients with early skin laxity, reduced firmness, or scarring who want gradual structural skin restoration may be reasonable candidates. As with any injectable treatment, a physician should assess your skin condition and health history beforehand to rule out contraindications and plan an individualised treatment approach.

Final ThoughtsAnchor

Karisma Rh Collagen is an interesting innovation within the bio-restorative filler category, using a collagen precursor structurally close to human collagen rather than relying on traditional inflammation-based stimulation. Preliminary scientific evidence supports its mechanism, but I recommend viewing this evidence with balance rather than taking "100% safe" marketing claims at face value, and always consulting a physician who genuinely understands the product's mechanism and limitations before deciding to proceed.

FAQ

How does Rh Collagen differ from injecting raw collagen or animal-derived collagen?

Rh Collagen isn't finished collagen added directly into the skin. It's a polypeptide precursor (α1 chain) that stimulates your own fibroblasts to produce type I collagen. This differs from older animal-derived collagen injections, which carried a higher allergy risk due to their structural difference from human collagen.

What side effects might occur?

As with any injectable procedure, bruising, swelling, redness, or localised reactions at the injection site are possible. These are generally mild and self-resolving, but treatment should always be performed by an experienced physician to minimise risk.

How fast do results appear, and how long do they last?

Since the mechanism relies on stimulating the body's own collagen production, results develop gradually rather than immediately. Duration depends on individual skin condition and the number of sessions performed — discuss an appropriate treatment schedule with your physician.

Can it be combined with fillers or other biostimulators?

In principle, since the mechanisms differ, combination may be possible in certain cases, but this should always be assessed individually by a physician rather than decided independently.

How reliable is the current research?

There are both in vitro cell studies and a clinical study in human subjects published in peer-reviewed journals — promising preliminary evidence. However, the body of research remains limited compared with products used clinically for decades, so continued long-term data and physician guidance remain important.

Sources & References

- Evaluation of the Effectiveness of an Innovative Polycomponent Formulation on Adult and Aged Human Dermal Fibroblasts (PMC, in vitro study on KARISMA Rh Collagen FACE). - New Regenerative and Anti-Aging Medicine Approach Based on Single-Stranded Alpha-1 Collagen for Neo-Collagenesis Induction: Clinical and Instrumental Experience of a New Injective Polycomponent Formulation for Dermal Regeneration (PMC, clinical study, n=100). - Manufacturer product information, Karisma Rh Collagen® FACE (Taumedika Srl, Rome, Italy).

Skin Booster